KARACHI – Center for Bioequivalence Studies and Clinical Research (CBSCR), University of Karachi (UoK), is offering for the first time in Pakistan a unique facility of ‘certified reference laboratory’ that would conduct bioequivalence evaluation and development of generic pharmaceutical products in full compliance with the regulatory authorities in Europe, USA and Japan.
Director International Center for Chemical and Biological Sciences (ICCBS-UoK) Prof. Dr. Muhammad Iqbal Choudhary stated this while talking to a delegation of scientists at ICCBS-UoK.
He said that the CBSCR, which was earlier known as Center for Bioequivalence Studies and Bioassay Research (CBSBR), at Dr. Panjwani Center for Molecular Medicine and Drug Research (PCMD) (International Center for Chemical and Biological Sciences), University of Karachi was providing services in the area of Bioequivalence Studies and Clinical Research to Pakistani pharmaceutical companies who could have a fairly good objective evaluation of their products.
“Pakistani pharmaceutical companies can avail this service to register their products in other countries where bioequivalence is mandatory. This can therefore have a significant impact on the export potential of the Pakistani companies. The improved quality of products in Pakistan will add largely to reduced cost of treatment, improved health, and more affordable treatment of diseases. The Center is also offering a full range of analytical method development, certification of assays, dispute resolution between drug companies and the ministries of health,” he said. The center have a potential to become a premier teaching facility for analytical method development and documentation leading to good laboratory practices and generate revenues for the institute, he said and adding that this is one of the greatest needs of the country to provide quality healthcare products.
He said, “Indeed the center will have large. The center is having, as one of its major function, complete testing facilities that include clinical monitoring of patents, blood sample analysis statistical analysis, and evaluation of equivalence of products. It is initially being funded by the government of Pakistan and ultimately it would become a profit-earning organization promotion research and academic activities in the country.”